Adverse Events and Autopsy Findings after Intravitreous Cidofovir (HPMPC) Therapy in Patients with Acquired Immune Deficiency Syndrome (AIDS)

This publication has 31 references indexed in Scilit:

• Oral Ganciclovir for the Prevention of Cytomegalovirus Disease in Persons with AIDS
  New England Journal of Medicine, 1996
• Liposome-Encapsulated (S)-1-(3-Hydroxy-2-Phosphonylmethoxypropyl)cytosine for Long-Acting Therapy of Viral Retinitis
  The Journal of Infectious Diseases, 1996
• Oral Ganciclovir as Maintenance Treatment for Cytomegalovirus Retinitis in Patients with AIDS
  New England Journal of Medicine, 1995
• Anticytomegaloviral activity and safety of cidofovir in patients with human immunodeficiency virus infection and cytomegalovirus viruria
  Antimicrobial Agents and Chemotherapy, 1995
• (S)-1-[3-Hydroxy-2-(Phosphonylmethoxy)propyl]cytosine (Cidofovir): Results of a Phase I/II Study of a Novel Antiviral Nucleotide Analogue
  The Journal of Infectious Diseases, 1995
• Intravitreal Ganciclovir Concentration after Intravenous Administration in AIDS Patients with Cytomegalovirus Retinitis: Implications for Therapy
  The Journal of Infectious Diseases, 1993
• A Randomized, Controlled Study of Intravenous Ganciclovir Therapy for Cytomegalovirus Peripheral Retinitis in Patients with AIDS
  The Journal of Infectious Diseases, 1993
• A Dose-Ranging Study of Daily Maintenance Intravenous Foscarnet Therapy for Cytomegalovirus Retinitis in AIDS
  The Journal of Infectious Diseases, 1993
• Mortality in Patients with the Acquired Immunodeficiency Syndrome Treated with either Foscarnet or Ganciclovir for Cytomegalovirus Retinitis
  New England Journal of Medicine, 1992
• A novel selective broad-spectrum anti-DNA virus agent
  Nature, 1986